Actavis Plc’ share price up, company approaching a $62.5-billion deal with Allergan Inc.
November 17, 2014 12:14 pm
People familiar with the situation reported that Actavis Plc is approaching the finalization of a deal with Allergan Inc. estimated to more than $64 billion. The deal is to allow Allergan to fend off a hostile takeover bid from Valeant Pharmaceuticals International Inc. The people, who asked not to be identified because the information is […] Read more